Skip to content
My WebMD Sign In, Sign Up

Breast Cancer Health Center

Font Size

Breast Cancer & Genes: Assessing Risk

Study Questions Accuracy of Genetic Risk Models Used to Determine Testing
By
WebMD Health News
Reviewed by Louise Chang, MD

serious woman

The study challenges the accuracy of models used to determine who should be offered testing for the breast cancer gene mutation BRCA, finding the models to be poor predictors of risk for women with few female relatives over the age of 45.

The models assess risk based on known family history of breast cancer.

"You have to have a family to have a family history," researcher Jeffrey Weitzel, MD, of the City of Hope Cancer Center in Duarte, Calif., tells WebMD.

He added that women with few older female relatives on either their mother's or father's sides were not well served by the available models.

Mutation Uncommon

Inherited gene mutations play a role in about 5% of all breast cancers. But women with BRCA1 or BRCA2 mutations have about a 50% to 85% lifetime risk of developing the disease, compared with a roughly 10% lifetime risk among the general population of women.

BRCAcarriers are also much more likely to develop breast cancers before the age of 50, and their risk for ovarian cancer is also greatly increased.

Identifying women with BRCA mutations is a proven strategy for reducing the risk of death from breast or ovarian cancer. But since the mutations are rare, testing all women or even testing all breast cancer patients may not be practical.

Most women who develop breast cancer before the age of 40 are considered for genetic testing, but clinicians often rely on the prediction models to determine whether women diagnosed in their 40s should be screened if they have no known family link to the disease.

Weitzel and colleagues assessed the accuracy of the prediction models in their study appearing in the June 20 issue of TheJournal of the American Medical Association.

A total of 1,543 breast cancer patients enrolled in a cancer registry between 1997 and 2007 were included in the study. Of these patients, 306 were diagnosed before age 50 and reported no known first- or second-degree relatives with breast or ovarian cancers.

When these women were questioned further about their family history, half of them (153) were determined by researchers to have too few close female relatives to accurately assess risk, defined as fewer than two females relatives age 45 or older on both their mother's and father's sides of the family.

Genetic testing revealed that these women had a 14% risk of having a mutation, compared with a 5% risk among women with a larger number of female relatives who survived to their mid-40s without developing breast cancer.

"The likelihood of finding a mutation was almost three times greater [among the women with fewer older female relatives]," Weitzel says. "We are clearly missing women who could benefit from knowing their genetic risk."

Today on WebMD

Breast Cancer Overview
From self-exams and biopsies to reconstruction, we’ve got you covered.
Dealing with breast cancer
Get answers to your questions.
 
woman having mammogram
Experts don’t agree on all fronts, but you can be your own advocate.
woman undergoing breast cancer test
Many women worry. But the truth? Most abnormalities aren’t breast cancer.
 
Breast Cancer Treatments Improving
VIDEO
Resolved To Quit Smoking
SLIDESHOW
 
Woman getting mammogram
Article
Screening Tests for Women
SLIDESHOW
 
ovarian cancer overview slideshow
SLIDESHOW
serious woman
Article
 
what is your cancer risk
HEALTH CHECK
10 Ways to Revitalize Slideshow
SLIDESHOW